CSIMarket


Boston Scientific Corporation  (BSX)
Other Ticker:  
 


 

Boston Scientific Corporation

BSX's Financial Statements and Analysis



Boston Scientific Corporation reported in II. Quarter net earnings per share of $0.17 an increase by 41.67 % year on year from $0.12 and an improvement of 142.86 % from $0.07 realized in I. Quarter (Mar 31 2022).


II. Quarter
Earnings Per Share Revenues
$ 0.17 $  3,244 Mill
$+0.05     +41.67 % $+167M     +5.43 %



Boston Scientific's Revenue rose by 5.43 % in II. Quarter (Jun 30 2022) year on year, to $3,244 million and advanced by 7.2 % sequentially.


Boston Scientific is Expected to report next financial results on November 03, 2022.

More on BSX's Income Statement





       
  • Cardiovascular 7.2% Y/Y,
• Electrophysiology 12.96% Y/Y,
• CARDIOVASCULAR GROUP 9.03% Y/Y,
• Endoscopy 6.47% Y/Y,
• Neuromodulation 11.3% Y/Y,
• Cardiac Rhythm Management 0.21% Y/Y
   
     
       
  • TOTAL ENDOSURGERY -24.27% Y/Y    
     


BSX's Segments

Boston Scientific's net income of $260.000 million in II. Quarter increased by 39.78 % from net earnings of $186.000 million achieved in II. Quarter a year ago.

Sequentially net earnings grew by 136.36 % from net income of $110.000 million realized in previous quarter.

More on BSX's Growth

Inventories grew by 22.52 % to $1,752 million from II. Quarter a year ago, sequentially inventories rose by 0.92 %. In II. Quarter company's net cash and cash equivalents decreased by $-71 million, capital expenditures grew by -0.94%, to $-105 millions compare to same quarter a year ago and rose by -13.22% from I. Quarter (Mar 31 2022).

More on BSX's Cash flow Statement


Boston Scientific Corporation payed out dividend of $0.04 per share in last 52 weeks representing 6.90 % of net earning per share in trailing twelve-month period.

During the same period Boston Scientific Corporation earned $ 0.83 cash per share, on a free-cash flow basis 142.94 % of net earning per share.

Book value grew by 3.13 % sequentially to $12.00 per share, 150.83% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -1.38 per share from $ -1.94.

Company repurchased 0.60 million shares or 0.04 % in II. Quarter.
Interest Coverage Ratio was 3.14. Debt Coverage Ratio was 0.18.

More on BSX's Dividends

 Market Capitalization (Millions) 60,603
 Shares Outstanding (Millions) 1,438
 Total Debt (Millions $) 8,972
 Revenue (TTM) (Millions $) 12,329
 Net Income (TTM) (Millions $) 884
 Cash Flow (TTM) (Millions $) -2,440
 Capital Exp. (TTM) (Millions $) -599
 Dividend TTM ($) 0.04 $
 Dividend Yield TTM (%) 0.09 %
 Employees (TTM) $ 36,000




Boston Scientific Corporation payed out dividend of $0.04 per share in last 52 weeks representing 6.90 % of net earning per share in trailing twelve-month period.

During the same period Boston Scientific Corporation earned $ 0.83 cash per share, on a free-cash flow basis 142.94 % of net earning per share.

Book value grew by 3.13 % sequentially to $12.00 per share, 150.83% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -1.38 per share from $ -1.94.

Company repurchased 0.60 million shares or 0.04 % in II. Quarter.
Interest Coverage Ratio was 3.14. Debt Coverage Ratio was 0.18.

More on BSX's Balance Sheets

 Market Capitalization (Millions) 60,603
 Shares Outstanding (Millions) 1,438
 Total Debt (Millions $) 8,972
 Revenue (TTM) (Millions $) 12,329
 Net Income (TTM) (Millions $) 884
 Cash Flow (TTM) (Millions $) -2,440
 Capital Exp. (TTM) (Millions $) -599
 Dividend TTM ($) 0.04 $
 Dividend Yield TTM (%) 0.09 %
 Employees (TTM) $ 36,000


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KYMR's Profile

Stock Price

KYMR's Financials

Business Description

Fundamentals

Charts & Quotes

KYMR's News

Suppliers

KYMR's Competitors

Customers & Markets

Economic Indicators

KYMR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071